Oral Levodopa in Congestive Heart Failure

Goldberg LI. RAJFER SI. Sympathomimetic amines: potential clinical applications in ischemic heart disease. Am Heart J 1982; 103(4 Pt 2):724–9.

Whitsett TL Goldberg LI. Effects of levodopa on systolic preejection period, blood pressure, and heart rate during acute and chronic treatment of Parkinson's disease. Circulation 1972; 45: 97–106.

Rajfer SI Anton AH Rossen JD Goldberg LI. Beneficial hemodynamic effects of oral levodopa in heart failure: relation to the generation of dopamine. N Engl J Med 1984; 310: 1357–62.

Maddox RW Arnold WS Sliger VO. Beneficial hemodynamic effects of oral levodopa in a patient with cardiomyopathy (let-ter). Clin Pharm 1985; 4: 502–4.

Gore I Chandler JW Gonzalez JL Rogers WJ. Oral levodopa in heart failure (letter). N Engl J Med 1984; 311: 671.

Shah PK Amin DK Horn E. Adverse clinical and hemodynamic effects of oral levodopa in chronic congestive heart failure. Am Heart J 1985; 110;488–9.

Marcus R Coulston AM. Water-soluble vitamins. In: Gilman AG Goodman LS Rall Tw Murad F , eds. Goodman and Gilman's the pharmacological basis of therapeutics. 7th ed. New York: Macmillan, 1985: 1551–72.

Goldberg LI Rajfer SI. Dopamine receptors: applications in clinical cardiology. Circulation 1985; 72: 245–8.